Risk Assessment
Watch the NC-stat DPNCheck Overview

NC-stat DPNCheck

NC-stat DPNCheck can improve the effectiveness of neuropathy detection programs and is ideal for:

• Health Risk Assessment Service Providers for In-home Use
• Clinic Based Health Risk Assessments

Why Use Nerve Conduction to Detect Diabetic Peripheral Neuropathy (DPN)?

The expected rate of neuropathy approaches 50%¹ but is often missed with traditional detection methods such as monofilament testing²

• Traditional detection tools (monofilament or tuning fork) detect only late stage neuropathy and have low sensitivity
• Due to the subjective nature of these tests they are usually performed by physicians not staff
• Compliance rates for the performance of these tests are typically poor
• Sural nerve conduction detects DPN with high diagnostic sensitivity at all stages of severity

Benefits of Improved DPN Detection in a Managed Care Organization:

• Accurately risk assess diabetes patients
• Early diagnosis of DPN presents opportunities to intervene and reduce costs
• Identify those patients with neuropathy that are at highest risk for neuropathy related complications such as foot ulcers, neuropathic pain, and falls – DPN related ulcers and amputations have 5 year mortality rates comparable to colon cancer and worse than other common cancers, click here to view mortality data
• Efficient and cost effective testing

DPNCheck Clinical Validation

The NC-stat DPNCheck has been clinically validated in numerous peer-reviewed journal publications and clinical conference presentations. Click here to view the complete list.